$NCNA UP 29+% TODAY!! 👀
Check out $NuCana (NCNA.US)$ Under $2.00 a share right now!
Some things to consider:
- NuCana’s market cap is not reflecting the potential of two other drug candidates NUC-3373 and NUC-7738, currently in Phase 2 trials.
- The UK and EU proceedings against Gilead for alleged years-long infringement of an EU patent have important hearing dates lined up in January and March 2023.
- Total overdue license fees / damages could be about $920 million, and infringement is ongoing at $450 million in EU sales per year.
-A reasonable 6% royalty could lead to a total of $920 million in overdue license fees / damages, and infringement by Gilead still ongoing.
- Cash runway until 2025 and almost 900 patents granted.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
RIPPER : What the Fdoes this have to do with GME?!